| Mr Bill Arthur Rudolph Jr, MA | |
|
4403 E Manchaca, Austin, TX 78745-1680 | |
| (512) 444-8684 | |
| (512) 444-8697 |
| Full Name | Mr Bill Arthur Rudolph Jr |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 4403 E Manchaca, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730249160 | NPI | - | NPPES |
| 514099 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 50378 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Bill Arthur Rudolph Jr, MA 4403 E Manchaca, Austin, TX 78745-1680 Ph: (512) 444-8684 | Mr Bill Arthur Rudolph Jr, MA 4403 E Manchaca, Austin, TX 78745-1680 Ph: (512) 444-8684 |
News Archive
Mannose sugar, a nutritional supplement, can both slow tumor growth and enhance the effects of chemotherapy in mice with multiple types of cancer.
Today's Medicare demonstration project might determine how physicians interact with the program tomorrow, so naturally such projects generate a lot of buzz in the health care community. Lately, some of that buzz has been about how demos might provide part of the solution for Medicare's payment problems.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has been awarded a contract valued at up to $24.7 million inclusive of options by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
The Arentz Law Group is currently investigating cases of birth defects caused by the stop-smoking drug Zyban. Women who have taken Zyban while pregnant, and given birth to a child born with a birth defect, are encouraged to contact the law firm immediately for a free legal consultation.
Ligand Pharmaceuticals Incorporated announced the signing of an exclusive global license agreement with TG Therapeutics, Inc. for the development and commercialization of Ligand's Interleukin-1 Receptor Associated Kinase-4 (IRAK-4) inhibitors.
› Verified 3 days ago
Dr. William Blunk, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3816 S 1st St, Austin, TX 78704 Phone: 512-443-1311 Fax: 512-406-6266 | |
Bhavana Kancherla, M.A., CCC/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1208 Tamranae Ct, Austin, TX 78746 Phone: 412-855-9296 | |
Carmen Tyler, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 211 Comal St, Austin, TX 78702 Phone: 512-978-9200 Fax: 512-978-9238 | |
Maribeth Collins, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3705 Medical Pkwy Ste 200, Austin, TX 78705 Phone: 512-324-2720 | |
Dr. Bart Edward Noble, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2901 S. Montopolis Dr., Austin, TX 78741 Phone: 512-389-6505 Fax: 512-389-6559 | |
Rachel C Spinuzza, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3607 Manor Rd Ste 101, Austin, TX 78723 Phone: 512-478-2273 Fax: 512-472-0921 | |
Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3201 Bee Caves Rd Ste 146, Austin, TX 78746 Phone: 512-327-8845 Fax: 512-327-8843 |